Unitree Robotics (宇树科技), one of China’s leading humanoid robot developers, has received registration approval for its initial public offering on Shanghai’s STAR Market, completing the process in just 104 days. The approval clears the way for what could become one of the most closely watched listings in the global robotics industry as investors increasingly focus on embodied AI and next-generation automation technologies.
The Hangzhou-based company plans to raise CNY 4.2 billion (US$576 million) through the offering. According to its prospectus, the proceeds will be used to expand manufacturing capacity, accelerate research and development of humanoid robots, and strengthen the company’s commercial and service network both in China and overseas.
The approval comes at a time when humanoid robotics has emerged as one of the most strategically important segments of China’s technology sector. Policymakers have repeatedly highlighted embodied AI—the integration of artificial intelligence with physical robotic systems—as a key frontier for industrial upgrading and future economic growth. Against that backdrop, Unitree’s rapid progress through the regulatory process underscores growing institutional support for the industry.
From Quadruped Robots to Humanoid Systems
Founded in 2016, Unitree initially gained recognition through its quadruped robots, which were widely adopted across research institutions, industrial inspection projects, and security applications. Products such as the Go2 and B2 series helped establish the company as one of the most recognizable robotics brands to emerge from China over the past decade.
In recent years, however, humanoid robots have become the company’s primary growth focus. Unitree’s G1 and H1 humanoid platforms have attracted attention for combining advanced mobility capabilities with relatively accessible pricing compared with many competing systems.
The company has focused on making humanoid robots available to a broader range of users, including manufacturers, research institutions, universities, and developers. This strategy has helped accelerate deployment across real-world environments, generating operational data that can be used to improve future product iterations.
As the commercialization of humanoid robots remains in its early stages globally, companies capable of scaling deployments beyond pilot projects may gain important advantages in product refinement, software development, and ecosystem building.
Competition Intensifies in the Global Humanoid Robot Market
Unitree’s public market debut comes amid intensifying competition among robotics companies worldwide. Several major technology firms and startups are investing heavily in humanoid robots as advances in artificial intelligence make increasingly sophisticated autonomous systems possible.
Among the most closely watched competitors is the Tesla Optimus project, which has attracted significant attention due to its long-term ambition of deploying humanoid robots across manufacturing and commercial environments. Other companies, including Agility Robotics, Boston Dynamics, Figure AI, and 1X Technologies, are pursuing their own commercialization strategies across logistics, industrial automation, and service applications.
While business models and product positioning vary significantly, the industry remains focused on a common challenge: moving humanoid robots from controlled demonstrations into scalable commercial deployments.
Unitree’s strategy has centered on affordability, rapid product iteration, and broad accessibility. By targeting a wider customer base, the company aims to accelerate deployment volumes and collect operational feedback that can inform future development cycles.
Expanding Global Commercialization
International markets are becoming increasingly important for robotics companies seeking scale. Labor shortages, aging populations, and rising automation demand are creating opportunities for humanoid robots across manufacturing, logistics, warehousing, and service industries.
Unitree has already established a presence in multiple overseas markets through both its quadruped and humanoid robot product lines. The company has supplied robots to research institutions, technology developers, and industrial users across North America, Europe, and Asia.
The IPO proceeds are expected to support additional investments in overseas distribution channels, technical support capabilities, certification processes, and localized service networks. These investments may prove critical as robotics companies move beyond prototype deployments and seek larger-scale commercial adoption.
A New Benchmark for China’s Embodied AI Industry
Beyond its own growth plans, Unitree’s listing carries broader significance for China’s robotics ecosystem. The company is among the highest-profile participants in the country’s rapidly expanding embodied AI sector, which has attracted substantial investment from venture capital firms, industrial groups, and government-backed funds.
A successful IPO could provide an important valuation benchmark for other Chinese robotics companies and help attract additional capital to the sector. Public market access may also strengthen confidence among international customers evaluating long-term robotics deployments, particularly in industries where reliability, support infrastructure, and financial stability are critical purchasing considerations.
Over the past decade, Shanghai’s STAR Market has played a major role in supporting the development of China’s semiconductor, biotechnology, and advanced manufacturing industries. Unitree’s listing represents another step in that evolution, highlighting growing investor interest in embodied AI and humanoid robotics as the next frontier of technological innovation.
As the global race to commercialize humanoid robots accelerates, Unitree’s IPO marks an important milestone not only for the company itself but also for China’s broader ambitions to become a leading force in the future of intelligent automation.